학술논문
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC
Document Type
Article
Author
Source
In Journal of Thoracic Oncology May 2019 14(5):793-801
Subject
Language
ISSN
1556-0864